Literature DB >> 28905881

Identification of ASAH1 as a susceptibility gene for familial keloids.

Regie Lyn P Santos-Cortez1, Ying Hu2,3, Fanyue Sun2, Fairouz Benahmed-Miniuk2, Jian Tao2, Jitendra K Kanaujiya2, Samuel Ademola4, Solomon Fadiora5, Victoria Odesina6, Deborah A Nickerson7, Michael J Bamshad7,8, Peter B Olaitan5, Odunayo M Oluwatosin4, Suzanne M Leal1, Ernst J Reichenberger2.   

Abstract

Keloids result from abnormal proliferative scar formation with scar tissue expanding beyond the margin of the original wound and are mostly found in individuals of sub-Saharan African descent. The etiology of keloids has not been resolved but previous studies suggest that keloids are a genetically heterogeneous disorder. Although possible candidate genes have been suggested by genome-wide association studies using common variants, by upregulation in keloids or their involvement in syndromes that include keloid formation, rare coding variants that contribute to susceptibility in non-syndromic keloid formation have not been previously identified. Through analysis of whole-genome data we mapped a locus to chromosome 8p23.3-p21.3 with a statistically significant maximum multipoint LOD score of 4.48. This finding was followed up using exome sequencing and led to the identification of a c.1202T>C (p.(Leu401Pro)) variant in the N-acylsphingosine amidohydrolase (ASAH1) gene that co-segregates with the keloid phenotype in a large Yoruba family. ASAH1 is an acid ceramidase known to be involved in tumor formation by controlling the ratio of ceramide and sphingosine. ASAH1 is also involved in cell proliferation and inflammation, and may affect the development of keloids via multiple mechanisms. Functional studies need to clarify the role of the ASAH1 variant in wound healing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905881      PMCID: PMC5602022          DOI: 10.1038/ejhg.2017.121

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  51 in total

1.  Clinical genetics of familial keloids.

Authors:  A G Marneros; J E Norris; B R Olsen; E Reichenberger
Journal:  Arch Dermatol       Date:  2001-11

2.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

Review 3.  Molecular dissection of abnormal wound healing processes resulting in keloid disease.

Authors:  Barbara Shih; Elloise Garside; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Wound Repair Regen       Date:  2009-12-11       Impact factor: 3.617

4.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.

Authors:  E Sobel; K Lange
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.

Authors:  Chi-Ming Li; Jae-Ho Park; Calogera M Simonaro; Xingxuan He; Ronald E Gordon; Adriana-Haimovitz Friedman; Desiree Ehleiter; Francois Paris; Katia Manova; Stefan Hepbildikler; Zvi Fuks; Konrad Sandhoff; Richard Kolesnick; Edward H Schuchman; Stefan Hepbiloikler
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

6.  Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1.

Authors:  Jie Zhou; Marcel Tawk; Francesco Danilo Tiziano; Julien Veillet; Monica Bayes; Flora Nolent; Virginie Garcia; Serenella Servidei; Enrico Bertini; Francesc Castro-Giner; Yavuz Renda; Stéphane Carpentier; Nathalie Andrieu-Abadie; Ivo Gut; Thierry Levade; Haluk Topaloglu; Judith Melki
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

Review 7.  Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy.

Authors:  Edward H Schuchman
Journal:  Biochim Biophys Acta       Date:  2016-05-04

8.  Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease.

Authors:  J Koch; S Gärtner; C M Li; L E Quintern; K Bernardo; O Levran; D Schnabel; R J Desnick; E H Schuchman; K Sandhoff
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

9.  Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models.

Authors:  Hashem A Shihab; Julian Gough; David N Cooper; Peter D Stenson; Gary L A Barker; Keith J Edwards; Ian N M Day; Tom R Gaunt
Journal:  Hum Mutat       Date:  2012-11-02       Impact factor: 4.878

10.  Altered lipid metabolism in the aging kidney identified by three layered omic analysis.

Authors:  Fabian Braun; Markus M Rinschen; Valerie Bartels; Peter Frommolt; Bianca Habermann; Jan H J Hoeijmakers; Björn Schumacher; Martijn E T Dollé; Roman-Ulrich Müller; Thomas Benzing; Bernhard Schermer; Christine E Kurschat
Journal:  Aging (Albany NY)       Date:  2016-03       Impact factor: 5.682

View more
  3 in total

Review 1.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 2.  Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.

Authors:  Carolina Duarte; Juliet Akkaoui; Chiaki Yamada; Anny Ho; Cungui Mao; Alexandru Movila
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

Review 3.  Mesenchymal stem cell therapy in hypertrophic and keloid scars.

Authors:  Christine Bojanic; Kendrick To; Adam Hatoum; Jessie Shea; K T Matthew Seah; Wasim Khan; Charles M Malata
Journal:  Cell Tissue Res       Date:  2021-01-02       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.